Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder

STUDY OBJECTIVES: Lemborexant (LEM) is a dual orexin receptor antagonist approved for treating adults with insomnia. We analyzed the efficacy (subjective sleep outcomes) and safety of LEM over 12 months in the subgroup of Asian subjects from Study E2006-G000-303 (Study 303). METHODS: Study 303 was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dash, Amitabh, Pinner, Kate, Inoue, Yuichi, Hayashida, Kenichi, Lim, Sung Chul, Yun, Chang-Ho, Lan, Tsuo-Hung, Huang, Chieh-Liang, Yardley, Jane, Kubota, Naoki, Moline, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987601/
https://www.ncbi.nlm.nih.gov/pubmed/35402894
http://dx.doi.org/10.1016/j.sleepx.2022.100044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987601/
https://www.ncbi.nlm.nih.gov/pubmed/35402894
http://dx.doi.org/10.1016/j.sleepx.2022.100044

Ejemplares similares